Vanguard Group’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.98M Sell
3,209,919
-1,164
-0% -$3.62K ﹤0.01% 2903
2025
Q1
$10.9M Sell
3,211,083
-4,358
-0.1% -$14.7K ﹤0.01% 2803
2024
Q4
$18.2M Buy
3,215,441
+29,014
+0.9% +$165K ﹤0.01% 2627
2024
Q3
$18.6M Buy
3,186,427
+147,863
+5% +$865K ﹤0.01% 2624
2024
Q2
$24M Sell
3,038,564
-193,134
-6% -$1.53M ﹤0.01% 2475
2024
Q1
$30.1M Buy
3,231,698
+702,030
+28% +$6.54M ﹤0.01% 2395
2023
Q4
$21.4M Buy
2,529,668
+47,711
+2% +$403K ﹤0.01% 2565
2023
Q3
$19.2M Buy
2,481,957
+6,131
+0.2% +$47.5K ﹤0.01% 2564
2023
Q2
$28.3M Buy
2,475,826
+511,146
+26% +$5.85M ﹤0.01% 2440
2023
Q1
$15.1M Buy
1,964,680
+9,508
+0.5% +$73.3K ﹤0.01% 2727
2022
Q4
$11.9M Buy
1,955,172
+58,358
+3% +$356K ﹤0.01% 2873
2022
Q3
$11.2M Sell
1,896,814
-93,073
-5% -$551K ﹤0.01% 2906
2022
Q2
$11.8M Buy
1,989,887
+62,100
+3% +$367K ﹤0.01% 2905
2022
Q1
$14.7M Sell
1,927,787
-144,258
-7% -$1.1M ﹤0.01% 2946
2021
Q4
$5.62M Sell
2,072,045
-90,829
-4% -$246K ﹤0.01% 3541
2021
Q3
$5.69M Sell
2,162,874
-6,099
-0.3% -$16K ﹤0.01% 3574
2021
Q2
$8.96M Sell
2,168,973
-284,939
-12% -$1.18M ﹤0.01% 3263
2021
Q1
$11.6M Buy
2,453,912
+36,261
+1% +$171K ﹤0.01% 3072
2020
Q4
$17.3M Buy
2,417,651
+169,855
+8% +$1.21M ﹤0.01% 2714
2020
Q3
$24M Sell
2,247,796
-23,492
-1% -$251K ﹤0.01% 2369
2020
Q2
$28.7M Sell
2,271,288
-53,647
-2% -$677K ﹤0.01% 2260
2020
Q1
$21.3M Buy
2,324,935
+231,887
+11% +$2.12M ﹤0.01% 2253
2019
Q4
$29.2M Buy
2,093,048
+324,339
+18% +$4.52M ﹤0.01% 2348
2019
Q3
$30.4M Buy
1,768,709
+196,847
+13% +$3.39M ﹤0.01% 2287
2019
Q2
$42.8M Buy
1,571,862
+180,087
+13% +$4.9M ﹤0.01% 2186
2019
Q1
$26.6M Buy
1,391,775
+8,015
+0.6% +$153K ﹤0.01% 2377
2018
Q4
$13M Buy
1,383,760
+187,166
+16% +$1.76M ﹤0.01% 2645
2018
Q3
$22.6M Buy
1,196,594
+113,442
+10% +$2.15M ﹤0.01% 2523
2018
Q2
$21.2M Buy
1,083,152
+136,057
+14% +$2.66M ﹤0.01% 2538
2018
Q1
$17.8M Sell
947,095
-3,807
-0.4% -$71.5K ﹤0.01% 2550
2017
Q4
$15.8M Buy
950,902
+249,803
+36% +$4.15M ﹤0.01% 2598
2017
Q3
$14.4M Buy
701,099
+270,334
+63% +$5.57M ﹤0.01% 2640
2017
Q2
$3.86M Buy
430,765
+13,194
+3% +$118K ﹤0.01% 3183
2017
Q1
$5.53M Buy
417,571
+35,447
+9% +$469K ﹤0.01% 3021
2016
Q4
$4.87M Buy
382,124
+35,539
+10% +$453K ﹤0.01% 3078
2016
Q3
$4.16M Buy
346,585
+33,992
+11% +$408K ﹤0.01% 3103
2016
Q2
$3.44M Buy
312,593
+292,900
+1,487% +$3.22M ﹤0.01% 3158
2016
Q1
$172K Buy
19,693
+1,718
+10% +$15K ﹤0.01% 3972
2015
Q4
$394K Buy
+17,975
New +$394K ﹤0.01% 3889